athenahealth's stock is down 5.28 percent since Jan. 2, where the price per share went from $135 to $128.
The company's 52-week range is $95.01 to $158.66.
However, a number of executives at the company engaged in insider trading activities within the past 12 months, which may offer insights into the stock's performance. These activities are legal insider trades, meaning corporate insiders — such as officers, directors and employees — are buying and selling stock in their own companies, according to the U.S. Securities and Exchange Commission.
Here are six things to know.
1. CEO Jonathan Bush sold 30,000 shares of the stock in a Dec. 26 transaction. The stock was sold at an average price of $134.90, for a total transaction value of $4.04 million, according to The Ledger Gazette.
2. After the sale, Mr. Bush owns 320,807 shares, valued at $43.2 million.
3. In October, Mr. Bush sold 4,000 shares of athenahealth stock at an average price of $124.17, for a total transaction of $496,680.
4. athenahealth Director Amy Abernethy sold 500 shares in a Dec. 26 transaction for an average price of $134.18. The total transaction was valued at $67,090, according to TrueBlueTribune.
5. After the sale, Ms. Abernethy owns 4,045 shares, valued at $542,758.10.
6. Over 2017, athenahealth officials sold $10.77 million in shares, but there was no insider buying.
More articles on EHRs:
Doylestown Hospital deploys eClinicalWorks' EHR
Default EMR setting could result in less ED opioid prescribing
Astria Health selects Cerner CommunityWorks for EHR, RCM system